New fat tissue injection passes first safety check in healthy volunteers
NCT ID NCT05518084
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a new cell-free fat tissue product, called Liponovo, is safe to inject into the skin. 38 healthy adults received an injection of the product in one arm and a plain saltwater solution in the other. Researchers monitored for side effects like redness, swelling, or allergic reactions over time. The trial is complete, but it only looked at safety, not whether the product works for any medical condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Liponovo tissue product (a cell-free fat tissue product)
What this could lead to
If proven safe, this product could be developed for future medical uses, such as tissue repair or cosmetic procedures.
What could go wrong
This was a very early safety study in healthy people, not patients. It does not test if the product works for any disease. Side effects may still appear in later studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY ISSUES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Terveystalo, Ruoholahti
Helsinki, Finland